Next, we sorted CD34+GPR56+ and CD34‐GPR56+ cells from two other primary AML samples and cultured the cells with Wnt antagonist PRI‐724, Hh agonist SAG, and TGFβ. This evidence concerns the gene CD34 and acute myeloid leukemia.